Sort
21,453 grants matching “tuberculosis”
Evaluating the safety, immunogenicity and efficacy of a robust attenuated Mtb vaccine in the setting of HIV co-infection
$905,998Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2025 · AI
Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection
$905,874Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2025 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$905,798Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$905,675Charles W. Flexner · Johns Hopkins University · U01 · FY2006 · AI
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
$905,202C Robert Horsburgh · Boston University Medical Campus · R01 · FY2021 · AI
Regulation of RANTES expression in T lymphocytes
$904,864Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Function of granulysin
$904,864Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$904,421Nitin S Baliga · Institute For Systems Biology · R01 · FY2022 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$904,277Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2019 · AI
Development of Vaccines to Prevent Tuberculosis
$903,787Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
A Neonatal Monkey Model for Tuberculosis Vaccination
$903,746Chinnaswamy Jagannath · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · AI
Clinical Trial Site Monitoring for PHOENIx MDR-TB
$903,544Kimberly Smith · Ppd Development Lp · N01 · FY2022 · AI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$903,535Mark Hatherill · University Of Cape Town · R01 · FY2020 · AI
Tuberculosis Elimination and Laboratory Cooperative Agreements
$903,410Jevon McFadden · Michigan State Department Of Health And Human Services · U52 · FY2014 · PS
Determining the role of sphingolipids in Mycobacterium tuberculosis infection
$903,202Fikadu G. Tafesse · Oregon Health & Science University · R01 · FY2020 · AI
Targeting protein secretion in Mycobacterium tuberculosis
$902,701Tanya Parish · Seattle Children'S Hospital · R01 · FY2024 · AI
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$902,060Nitin S Baliga · Institute For Systems Biology · R01 · FY2019 · AI
Dissecting the molecular targets to overcome beta-lactam resistance in M. abscessus complex
$901,706Barry Neal Kreiswirth · Hackensack University Medical Center · R01 · FY2025 · AI
A Resource for Biomedical Mass Spectrometry
$901,678Michael L Gross · Washington University · P41 · FY2011 · RR
Innovative Strategies to Improve Tuberculosis Diagnostics in Children
$900,727Molly Forrest Franke · Harvard Medical School · U19 · FY2014 · AI
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
$900,696C Robert Horsburgh · Boston University Medical Campus · R01 · FY2018 · AI
A systems approach to manipulate microbial adaptation to structured environments
$900,470Nitin S Baliga · Institute For Systems Biology · R01 · FY2020 · AI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
$900,000Raphael Dolin · Beth Israel Deaconess Medical Center · UM1 · FY2020 · AI
Closing -TB GAPs - for people living with HIV: TB Guidance for Adaptable Patient-Centered Service
$900,000Anna M Mandalakas · Baylor College Of Medicine · U01 · FY2020 · GH
AIDS 2024, the 25th International AIDS Conference, Munich, Germany, and virtually 22-26 July 2024
$900,000Chris Beyrer · Ias · R13 · FY2024 · AI